Clinical trial

HSK7653 Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus

NCT04564872

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-11-13

PhasePHASE3

Study timeline

Study start (actual)2020-11-13Date precision: day

Registry last updated2022-12-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

HSK7653 10 mg Q2WDRUG

HSK7653 25 mg Q2WDRUG

Linagliptin 5 mg QDDRUG

Sponsors & collaborators

Sichuan Haisco Pharmaceutical Group Co., Ltdlead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04564872 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.